Abstract
This article reviews if local immunosuppression of atopic dermatitis is associated with an increased risk of cancer - as implicated by a warning issued by the FDA and EMEA health authorities because systemic immunosuppression of transplanted patients leads to a significant increase of non-melanoma skin cancer and lymphoma. So far, no studies support that the use of topical immunosuppression increases the risk of local or systemic cancer.
Udgivelsesdato: 2009-Aug
Udgivelsesdato: 2009-Aug
Translated title of the contribution | Topical immune modulation and risk of cancer |
---|---|
Original language | Danish |
Journal | Ugeskrift for læger |
Volume | 171 |
Issue number | 35 |
Pages (from-to) | 2468-71 |
Number of pages | 4 |
ISSN | 0041-5782 |
Publication status | Published - 2009 |